Aberdeen Group’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-51,613
Closed -$430K 918
2022
Q4
$430K Buy
51,613
+2,502
+5% +$23.5K ﹤0.01% 848
2022
Q3
$461K Buy
49,111
+6,817
+16% +$86.3K ﹤0.01% 847
2022
Q2
$597K Buy
42,294
+92
+0.2% +$1.38K ﹤0.01% 844
2022
Q1
$714K Buy
42,202
+6,827
+19% +$113K ﹤0.01% 861
2021
Q4
$832K Buy
35,375
+2,789
+9% +$64.6K ﹤0.01% 901
2021
Q3
$712K Sell
32,586
-1,270
-4% -$30.9K ﹤0.01% 931
2021
Q2
$932K Buy
33,856
+21,199
+167% +$583K ﹤0.01% 887
2021
Q1
$334K Buy
+12,657
New +$346K ﹤0.01% 941

Other funds holding CLVT

Aberdeen Group's CLVT Position: Q1 2023 in Review

Aberdeen Group sold out of Clarivate (CLVT) in Q1 2023, closing a stake of 51,613 shares — an estimated $430K sold.

Aberdeen Group first reported a position in CLVT in Q1 2021 and held it in 8 quarters. The position peaked at $932K in Q2 2021. 294 funds tracked by Wall St. Rank hold CLVT as of Q1 2023.

  • Aberdeen Group reported no remaining Clarivate position as of Q1 2023 after selling out during the quarter.
  • Aberdeen Group sold 51,613 Clarivate shares in Q1 2023, an estimated $430K.
  • Aberdeen Group first reported a position in Clarivate in Q1 2021 and held it in 8 quarters.
  • Aberdeen Group's Clarivate position peaked at $932K in Q2 2021.
  • 294 funds tracked by Wall St. Rank held Clarivate as of Q1 2023.

Based on Aberdeen Group's 13F filing for Q1 2023, filed 28 Apr 2023.